SCbioDrive Launches Its First Cohort of Startups
SCbio has launched the SCbioDrive accelerator, bringing together seven early-stage life science startups for focused mentorship, expert guidance, and a clear, week-by-week curriculum. The program zeroes in on oncology and neuroscience, helping teams advance both their science and their business so they can move further, faster.
Global Participation and Impact
This inaugural class draws founders from across the map—Boston, New York, Florida, and even Taiwan—underscoring the reach of the initiative and the appetite for what it offers. That mix isn’t accidental. It reflects the momentum SCbio is building on a global stage and points to South Carolina’s growing pull as a life sciences hub. President and CEO James Chappell has emphasized how this diversity strengthens the cohort while signaling the state’s rising profile in the industry.
How the Program Works
SCbioDrive is a semiannual accelerator built for seed-stage life sciences companies. Over eight weeks, founders work through a hybrid experience that blends targeted online sessions with in-person time to ensure real progress on both technology and strategy. The program is offered at no cost to participating startups, removing a common barrier and letting teams focus on what matters: development, learning, and execution.
Mentors and Learning
A key feature of the accelerator is its business-focused curriculum, delivered by industry experts from a range of sectors. The sessions are designed to help founders build practical, transferable skills—market understanding, commercialization thinking, and the day-to-day know-how required to navigate the complex life sciences landscape. The goal is simple: equip each team with the tools to make sound decisions in a high-stakes environment.
Meet the Startups of SCbioDrive
The Fall 2024 cohort brings together seven teams tackling urgent problems across oncology and neuroscience:
- Booster Biosciences is applying innovative biological models from Harvard Medical School to uncover resistance mechanisms and engineer new therapeutics, with a strong emphasis on cancer.
- Cell BioEngines Inc. is developing allogeneic stem cells to treat hematopoietic neoplasms. Its lead program has advanced to a Phase 1 clinical trial.
- Define Therapeutics Inc. is creating targeted therapies for difficult-to-treat prostate cancers, with a particular focus on CRPC and NEPC.
- Jaya Biosciences Inc. is building CNS-directed gene therapies for neurodegenerative diseases, leveraging discoveries tied to specific genetic mutations.
- RephImmune Biotechnology is advancing cellular immunotherapies designed to fight solid tumors and offer options to patients with limited treatments.
- Torpedo Bio is addressing pancreatic cancer by engineering anti-tumor regulatory T cells, aiming to improve outcomes in solid tumors where current approaches often fall short.
- Vova Ida Therapeutics Inc. (VIT) is focused on therapies for neurodegenerative disorders, with programs centered on restoring critical cellular functions.
What’s Next for the Cohort
The program culminates in a Demo Day, where all seven companies will share their progress and plans with investors and industry leaders. It’s a milestone moment—an opportunity to showcase traction, gather real-world feedback, and build the relationships that help young companies grow.
About SCbio
SCbio is South Carolina’s member-driven economic development organization for the life sciences. Representing more than 1,000 organizations and over 87,000 professionals across areas such as pharmaceuticals, medical devices, and digital health, SCbio works to support the companies and people building the sector statewide.
Frequently Asked Questions
What is SCbioDrive?
SCbioDrive is a semiannual accelerator for seed-stage life sciences companies. Over eight weeks, startups receive mentorship and a business-focused curriculum in a hybrid format—and there’s no cost to participate.
What fields do the participating startups focus on?
The cohort is centered on oncology and neuroscience. Teams are working on areas such as solid tumors, prostate cancer, pancreatic cancer, and neurodegenerative diseases.
Who are the key partners involved in SCbioDrive?
SCbioDrive collaborates with leaders across the industry, including MassBio, to provide support, expertise, and resources for participating startups.
What is the duration of the SCbioDrive program?
The program runs for eight weeks and uses a hybrid approach—online sessions paired with in-person engagements—culminating in a Demo Day for investors and industry leaders.
How can I learn more about SCbio and its initiatives?
For updates on SCbio and its programs, visit the organization’s official website to see news, events, and opportunities as they’re announced.
